Skip to main content

EDITORIAL article

Front. Vet. Sci., 17 September 2024
Sec. Veterinary Infectious Diseases
This article is part of the Research Topic Pathogenic mechanism of porcine viral disease View all 11 articles

Editorial: Pathogenic mechanism of porcine viral disease

  • 1Guangdong Provincial Key Laboratory of Animal Molecular Design and Precise Breeding, College of Animal Science and Technology, Foshan University, Foshan, China
  • 2Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China
  • 3University of California, San Francisco, San Francisco, CA, United States

Editorial on the Research Topic
Pathogenic mechanism of porcine viral disease

1 Introduction

Porcine viral disease is the most serious disease in the pig industry. Bacterial diseases have been widely controlled because of the use of antibiotics. Although some drugs or vaccines have been used in viral diseases, many of them are not effective and the treatment cost is high (1). And many of them stay in the laboratory exploration stage, and it is difficult to conduct large-scale experiments in clinical productions. Exploring the pathogenesis of animal viral diseases is helpful to the pathogenesis research of viral diseases, the rational use of drugs and vaccines, and the development of new vaccines. Nowadays, new viral diseases are constantly emerging in swine diseases, including the recombination and variation of old viral diseases, and the emergence and cross-species transmission of new viruses. Taking China as an example, in recent years, a new variant PRRSV NADC-34 strain appeared in 2014 (2), and the African classical swine fever virus appeared in 2018 (3). The old virus has not been eliminated, and new viruses have appeared, which makes the disease prevention and control of pigs increasingly complicated.

There are many reasons behind it, including the variation of natural climate and the unreasonable abuse of vaccines. Many factors lead to more and more animal diseases.

2 Organization of the Research Topic

The theme of this Research Topic mainly discusses the Pathogenic mechanism of porcine viral disease. This Research Topic has received 30 manuscripts, 10 manuscripts (two reviews, one opinion, one brief report, and six original articles) were accepted, 20 papers were rejected, the acceptance rate was 33.3%, and two Manuscript Summaries were also received. This Research Topic covers porcine reproductive and respiratory syndrome virus (PRRSV), pseudorabies virus (PRV), and Senecavirus A virus and porcine epidemic diarrhea virus (PEDV). These manuscripts were from nine laboratories in China, Hungary, Britain, and Namibia.

Ren et al. constructed a multiplex qRT-PCR method, which can distinguish PEDV, B. hyodysenteriae, and L. intracellularis. These three diseases are often shown as mixed infection in clinic diseases. Guo et al. successfully constructed a new infectious clone against the current epidemic PRRSV strain, and successfully saved the virus, laying a foundation for studying the characteristics of the new strain. Senecavirus A (SVA) does great harm to pig industry. Li, Chu et al. made a transcriptome analysis of cells infected by Senecavirus A and found 565 upregulated and 63 downregulated ones, which laid a foundation for revealing the infection mechanism of this virus. Opriessnig et al. developed a weaned piglet intubation model, and all vaccinated pigs showed strong immune responses and maintained protection against PRRSV attack. Xu et al. identified the protein that interacts with the N protein of PEDV through interactive genomics, such as the second-largest subunit of RNA polymerase II (RPB2) and uridine phosphorylase 1 (UPP1), both of which are involved in nucleotide metabolism. Overexpression of RPB2 was observed to significantly promote viral replication, while overexpression of UPP1 was found to inhibit viral replication significantly. The study of the interaction between PEDV N and host proteins provides a theoretical foundation for further exploration of the pathogenic mechanisms and strategies for the prevention and control of PEDV. Li, Liu et al. specifically explored the role and mechanism of RNA recombination in Senecavirus A, suggesting that attention should be paid attention. Jakab et al. demonstrated the development of a tiling amplicon sequencing protocol for the analysis of genome sequence stability in the context of the modified live PRRSV vaccine strain, Porcilis MLV. The results indicated that ARTIC-style protocols can be employed in the evaluation of genomic stability in PRRS MLV strains. Molini et al. detected PRRSV in Africa for the first time, which is type I and may be introduced from Europe. Tan et al. identified the proteins that interacted with the host during the adsorption and invasion of PRV infection, which laid the foundation for further research. Pei et al. summarized that differences in genetic background lead to different biological shapes, including resistance to PRRSV, internal immunological mechanism, mechanism of entering cells, differences in symptoms and lesions after infection, differences in viral load, and differences in non-coding RNA.

3 Conclusion

This Research Topic reveals the interaction and replication mechanism of different viruses from many aspects, which is helpful to further reveal the replication mechanism of these viruses and provide theoretical reference for controlling these diseases in the future.

Author contributions

MZ: Writing – original draft. XZ: Writing – review & editing. LY: Writing – review & editing. WK: Writing – review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by the Characteristic Innovation Project of Guangdong Provincial Department of Education (2023KTSCX128) and National Natural Science Foundation of China (31902279).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Vu HLX, McVey DS. Recent progress on gene-deleted live-attenuated African swine fever virus vaccines. NPJ Vaccines. (2024) 9:60.

Google Scholar

2. Tian K. NADC30-like porcine reproductive and respiratory syndrome in China. Open Virol J. (2017) 11:59–65.

PubMed Abstract | Google Scholar

3. Ge S, Li J, Fan X, Liu F, Li L, Wang Q, et al. Molecular characterization of African Swine Fever Virus, China, 2018. Emerg Infect Dis. (2018) 24:2131–3. doi: 10.3201/eid2411.181274

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: swine viral diseases, PRRSV, pathogenic mechanism, PRV, PEDV

Citation: Zhao M, Zhang X, Yu L and Kong W (2024) Editorial: Pathogenic mechanism of porcine viral disease. Front. Vet. Sci. 11:1488296. doi: 10.3389/fvets.2024.1488296

Received: 29 August 2024; Accepted: 03 September 2024;
Published: 17 September 2024.

Edited and reviewed by: Michael Kogut, Agricultural Research Service, United States Department of Agriculture, United States

Copyright © 2024 Zhao, Zhang, Yu and Kong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lingxue Yu, eXVsaW5neHVlJiN4MDAwNDA7c2h2cmkuYWMuY24=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.